Oesophagal diseases

Scott-Brown's Otorhinolaryngology: Head and Neck Surgery

Volumn , Issue , 2008, Pages 2062-2073

  Mason, Robert C ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955092461     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (50)

1. Cherian P, Smith LF, Bardham KD, Thorpe JAC, Oakley GD, Dawson D. Oesophageal testing in the evaluation of non-cardiac chest pain. Diseases of the Esophagus. 1995; 5: 129-33.
2. Jamieson JR, Stein HJ, De Meester TR, Bonavina L, Schwizer W, Hinder RA. Ambulatory 24-h oesophageal pH monitoring: normal values, optimum thresholds, specification, sensitivity, and reproducibility. American Journal of Gastroenterology. 1992; 87: 1102-11.
3. Marshall REK, Anggiansah A, Owen WJ. Bile in the oesophagus: clinical relevance and ambulatory detection. British Journal of Surgery. 1997; 84: 21-8.
4. Lundell LL, Abrahamson H, Ruth M. Longterm results of a prospective randomised comparison of total fundic wrap (Nissen Rosetti) or hemifundoplication (Toupet) for gastrooesophageal reflux. British Journal of Surgery. 1996; 83: 830-5.
5. Watson DI, Jamieson GG, Pike GK, Davies N, Richardson M, Devitt PG. A prospective randomised double-blind trial between laparoscopic Nissen fundoplication and anterior partial fundoplication. British Journal of Surgery. 1999; 86: 123-30.
6. Spechler JJ, Gogal RK. The columnar lined oesophagus, intestinal metaplasia and Norman Barrett. Gastroenterology. 1996; 110: 614-21.
7. Heitmiller RF, Redmond M, Hamilton SR. Barretts oesophagus with high grade dysplasia: an indication for prophylactic esophagectomy. Annals of Surgery. 1996; 224: 66-71.
8. Tack J, Janssens J, Vantrappen G. Non surgical treatment of achalasia. Hepatogastroenterology. 1991; 38: 493-7.
9. Barham CP, Gotley DC, Fowler A, Mills A, Alderson D. Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry. Gut. 1997; 41: 151-5.
10. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993; 104: 510-3.
11. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. British Journal of Surgery. 1998; 85: 1457-9.
12. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichmaier H. Surgical therapy of oesophageal carcinoma. British Journal of Surgery. 1990; 77: 845-57.
13. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. British Journal of Surgery. 1998; 85: 840-4.
14. Blazeby JM, Williams MH, Brooks ST, Alderson D, Farndon JR. Quality of life measurement in patients with oesophageal cancer. Gut. 1995; 37: 505-8.
15. Lerut T, Deleyn P, Cooseman W. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Annals of Surgery. 1992; 216: 583-90.
16. Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I. Hospital volume and surgical mortality in the United States. New England Journal of Medicine. 2002; 346: 1128-37.
17. Rankin S, Mason R. Staging of oesophageal carcinoma. Clinical Radiology. 1992; 46: 373-7.
18. Orringer MB. Transhiatal esophagectomy without thoracotomy for carcinoma of the thoracic esophagus. Annals of Surgery. 1984; 200: 282-8.
19. Alderson D, Courtney SP, Kennedy RH. Radical transhiatal oesophagectomy under direct vision. British Journal of Surgery. 1994; 81: 404-7.
20. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Annals of Surgery. 1994; 220: 364-72.
21. Sutton DN, Wayman J, Griffin SM. Learning curve for oesophageal cancer surgery. British Journal of Surgery. 1998; 85: 1399-402.
22. Skinner DB. En bloc resection neoplasms of the eosophagus and cardia. Journal of Thoracic and Cardiovascular Surgery. 1983; 85: 59-71.
23. Matthews HR, Steel A. Left-sided subtotal oesophagectomy for carcinoma. British Journal of Surgery. 1987; 74: 1115-7.
24. Luketich JD, Schauer PR, Christie NA, Weigel TL, Raja S, Fernando HC et al. Minimally invasive esophagectomy. Annals of Thoracic Surgery. 2000; 70: 906-11.
25. Rindani R, Martin CJ, Cox MR. Transhiatal versus Ivor-Lewis oesophagectomy: is there a difference? Australia and New Zealand Journal of Surgery. 1999; 69: 187-94.
26. Cheung HC, Siu KF, Wong J. Is pyloroplasty necessary in oesophageal replacement by stomach? A prospective randomised controlled trial. Surgery. 1987; 102: 19-24.
27. Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two field lymphadenectomy. British Journal of Surgery. 2000; 87: 1426-33.
28. Arnott SJ, Duncan W, Gignoux M, Girling DJ, Hansen HS, Launois B et al. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesphageal Collaborative Cancer Group). International Journal ofRadiology, Oncology, Biology, Physics. 1998; 41: 579-83.
29. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessey TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. New England Journal of Medicine. 1996; 335: 462-7.
30. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. New England Journal of Medicine. 1998; 339: 1979-84.
31. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M et al. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine. 2006; 355: 11-20.
32. MacDonald JS, Smalley SR, Beneditti J, Hundahl SA, Estes NC, Stemmermann GN. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New England Journal of Medicine. 2001; 345: 725-30.
33. Tan BS, Mason RC, Adam A. Minimally invasive therapy for advanced oesophageal malignancy. Clinical Radiology. 1996; 51: 828-36.
34. Alderson D, Wright PD. Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia. British Journal of Surgery. 1990; 77: 1151-3.
35. Carazzone A, Bonavina L, Segalin A, Ceriani C, Peracchia A. Endoscopic palliation of oesophageal cancer: results of a prospective comparison of Nd:YAG laser and ethanol injection. European Journal of Surgery. 1999; 165: 351-6.
36. Low DE, Paglerio KM. Prospective randomized clinical trial comparing brachytherapy and laser photoablation for palliation of esophageal cancer. Journal of Thoracic and Cardiovascular Surgery. 1992; 104: 173-8.
37. Sargeant IR, Tobias JS, Blackman G, Thorpe S, Glover JR, Bown SG. Radiotherapy enhances laser palliation of malignant dysphagia: a randomised study. Gut. 1997; 40: 362-9.
38. Spencer GM, Thorpe SM, Blackman GM, Solano J, Tobias JS, Lovat LB et al. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Gut. 2002; 50: 224-7.
39. Highley MS, Parnis FX, Trotter GA, Houston SJ, Penson RT, Harper PG et al. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. British Journal of Surgery. 1994; 81: 1763-5.
40. Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. New England Journal of Medicine. 1993; 329: 1302-7.
41. De Palma DG, di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointestinal Endoscopy. 1996; 43: 478-82.
42. Sanyika C, Corr P, Haffejee A. Palliative treatment of oesophageal carcinoma - efficacy of plastic versus self-expandable stents. South African Medical Journal. 1999; 89: 640-3.
43. Adam A, Ellul J, Watkinson AF, Tan BS, Morgan RA, Saunders MP et al. Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology. 1997; 202: 344-8.
44. Konigsrainer A, Riedmann B, De Vries A, Ofner D, Spechtenhauser B, Aigner F et al. Expandable metal stents versus laser combined with radiotherapy for palliation of unresectable esophageal cancer: a prospective randomized trial. Hepato-gastroenterology. 2000; 47: 724-7.
45. Dallal HJ, Smith GD, Grieve DC, Ghosh S, Penman ID, Palmer KR. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointestinal Endoscopy. 2001; 54: 549-57.
46. Cantero R, Torres AJ, Hernando F, Gallego J, Lezana A, Suarez A et al. Palliative treatment of esophageal cancer: self-expending metal stents versus Postlethwait technique. Hepato-gastroenterology. 1999; 46: 971-6.
47. Jones WG, Ginsberg RJ. Oesophageal perforation, a continuing challenge. Annals of Thoracic Surgery. 1992; 53: 534-43.
48. Tyrell MR, Trotter GA, Adam A, Mason RC. The incidence and management of laser-associated oesophageal perforation. British Journal of Surgery. 1995; 82: 1257-8.
49. Morgan RA, Ellul JPM, Denton ER, Glynos M, Mason RC, Adam A. Malignant esophageal fistulas and perforation: management with plastic-covered metallic endoprostheses. Radiology. 1997; 204: 527-32.
50. Ellul JPM, Morgan R, Gold D, Dussek J, Mason RC, Adam A. Parallel self-expanding covered metal stents in the trachea and oesophagus for the palliation of complex high tracheo-oesophageal fistula. British Journal of Surgery. 1996; 83: 1767-8.